Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Anesth Prog ; 68(4): 235-237, 2021 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-34911063

RESUMEN

We describe a case of massive epistaxis that occurred after removal of a nasal endotracheal tube, prompting emergent reintubation. Mask ventilation could not be performed because the nasal cavity was packed with gauze and the airway was being evacuated with a suction catheter. Therefore, instead of inhalational anesthetics and muscle relaxants, boluses of midazolam and remifentanil were administered, and reintubation was promptly performed. Sedation was maintained with dexmedetomidine infusion and midazolam. Nasal cautery was performed near the left sphenopalatine foramen. The patient was extubated without agitation or additional hemorrhage. Immediate recognition of the potential for airway loss, sufficient control of active bleeding, and drug selection in accordance with the emergent circumstances enabled prompt resecuring of the airway without pulmonary aspiration of blood.


Asunto(s)
Extubación Traqueal , Epistaxis , Extubación Traqueal/efectos adversos , Cauterización/efectos adversos , Epistaxis/etiología , Epistaxis/terapia , Humanos , Intubación Intratraqueal/efectos adversos , Mucosa Nasal , Succión/efectos adversos
2.
Immunopharmacol Immunotoxicol ; 34(2): 216-21, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21851322

RESUMEN

CONTEXT: Brain oxidative reactions are involved in epilepsy as well as neurodegenerative diseases. In animal convulsion models, some anticonvulsants have been found to suppress oxidative reactions associated with convulsions. However, the effect of anticonvulsants on brain oxidative reactions has not fully been clarified. OBJECTIVE: Midazolam and phenobarbital are often used as an intravenous anesthetic, and are known to have anticonvulsive effect, but antioxidative effect of these drugs has rarely been studied. Thus, the purpose of this study was to evaluate the effects of these drugs on the degree of convulsions and brain oxidative reactions in an animal convulsion model. MATERIALS AND METHODS: In order to evaluate brain oxidative reactions, we measured malondialdehyde (MDA) level and heme oxygenase (HO)-1 mRNA expression level in the brain of mice in a convulsion model generated by a single injection of pentylenetetrazole (PTZ). We evaluated the effects of midazolam and phenobarbital on the degree of PTZ-induced convulsions and on the changes in brain MDA level and HO-1 mRNA expression level. RESULTS: After PTZ injection, severe convulsions were observed in all mice. MDA level was increased in the whole brain, while HO-1 mRNA expression level was increased only in the hippocampus. Both midazolam and phenobarbital prevented the convulsions and suppressed the increase in both MDA level and HO-1 mRNA expression level in the brain. CONCLUSION: In this study, both midazolam and phenobarbital suppressed PTZ-induced MDA and HO-1 reactions in the brain, suggesting that these drugs inhibit brain oxidative reactions in a convulsion model.


Asunto(s)
Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Midazolam/farmacología , Pentilenotetrazol/farmacología , Fenobarbital/farmacología , Convulsiones/metabolismo , Animales , Corteza Cerebral/metabolismo , Modelos Animales de Enfermedad , Expresión Génica/efectos de los fármacos , Expresión Génica/genética , Hemo-Oxigenasa 1/genética , Hipocampo/metabolismo , Hipotálamo/metabolismo , Masculino , Malondialdehído/metabolismo , Ratones , Midazolam/uso terapéutico , Oxidación-Reducción/efectos de los fármacos , Fenobarbital/uso terapéutico , Convulsiones/inducido químicamente , Convulsiones/diagnóstico , Convulsiones/prevención & control , Resultado del Tratamiento
3.
Immunopharmacol Immunotoxicol ; 34(1): 79-83, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21854184

RESUMEN

CONTEXT: Interleukin-6 (IL-6) plays an important role in immune and inflammatory responses. Midazolam has been reported to modulate IL-6 response. Cyclooxygenase (COX) inhibitors, which are used together with midazolam in some patients undergoing surgery, also modulate it. We hypothesized that their combination results in eliciting the synergistical effect on the IL-6 response. OBJECTIVE: The aim of the present study was to evaluate the effect of the combination of midazolam and a COX inhibitor on IL-6 production. MATERIALS AND METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated from healthy volunteers and incubated with lipopolysaccharide (LPS), midazolam, and/or COX inhibitors, including indomethacin, SC-560, a COX-1 selective inhibitor, and NS-398, a COX-2 selective inhibitor. The supernatant concentrations of IL-6 and prostaglandins (PGs), including PGE2, PGF2α, PGD2, and 15-deoxy-Δ¹²,¹4-prostaglandin J2 (15dPGJ2) were measured. RESULTS: Midazolam had no effect on IL-6 production in the cells incubated for 12 h, and any COX inhibitors also had no effect. However, the combination of midazolam and NS-398 significantly inhibited it. Midazolam raised the concentration of 15dPGJ2 in the supernatant of the cells, but not the concentration of other PGs. DISSCUSSION AND CONCLUSION: The results in the present study demonstrated that the combination of midazolam and a COX-2 inhibitor inhibited LPS-induced IL-6 production in human PBMCs even if each drug separately did not have any effect on it. The finding suggests that their combination is effective against excessive IL-6 production such as severe inflammatory response and that the effect of midazolam on IL-6 production is possibly elicited via 15dPGJ2.


Asunto(s)
Ansiolíticos/farmacología , Inhibidores de la Ciclooxigenasa 2/farmacología , Interleucina-6/biosíntesis , Leucocitos Mononucleares/metabolismo , Lipopolisacáridos/farmacología , Midazolam/farmacología , Nitrobencenos/farmacología , Sulfonamidas/farmacología , Adulto , Ansiolíticos/agonistas , Sinergismo Farmacológico , Femenino , Humanos , Leucocitos Mononucleares/citología , Masculino , Midazolam/agonistas , Nitrobencenos/agonistas , Prostaglandina D2/análogos & derivados , Prostaglandina D2/biosíntesis , Sulfonamidas/agonistas
4.
Open Dent J ; 5: 146-9, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21915228

RESUMEN

Some dental patients have histories of adverse reactions to local anesthesia. The aim of the present study was to investigate the frequency of allergy to local anesthetics of dental patients who had histories of adverse reactions to local anesthesia based on the results of allergy tests in our institute over a period of 5 years. We investigated the past medical records of dental patients retrospectively, and twenty patients were studied. Three of the 20 showed a positive or false-positive reaction in the intracutaneous test, and one patient showed a false-positive reaction in the challenge test. Our results suggest that the frequency of allergy to local anesthetics is low even if patients have histories of adverse reactions to local anesthesia. However, allergy tests of local anesthetics should be performed in patients in whom it is uncertain whether they are allergic.

5.
Redox Rep ; 16(3): 114-20, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21801493

RESUMEN

Iron, a source of oxidative stress, plays a major role in the pathology of neurodegenerative disease. In Alzheimer's disease, the hippocampus is vulnerable to oxidative stress, leading to impairment in memory formation. In our previous study, a brain oxidative reaction was induced after intraperitoneal injection of ferric nitrilotriacetate (Fe-NTA). However, since only a small amount of iron reached the brain in the previous study, Fe-NTA was administered into the hippocampus using an osmotic pump in this study. After continuous injection of Fe-NTA for 2 weeks, a high level of apoptotic change was induced in the hippocampus, in accordance with the iron localization. After injection for 4 weeks, the hippocampus was totally destroyed. A small amount of iron infiltrated into the cerebral cortex and the striatum, and deposition was observed at the choroid plexus and ependymal cells. However, no apoptotic reaction or clear tissue injury was observed in these areas. In addition, muscarinic acetylcholine receptors (M1, M2, and M4) were decreased in both the cortex and hippocampus while it increased in the striatum. Thus, the hippocampus is likely vulnerable to oxidative stress from Fe-NTA, and the oxidative stress is considered to bring the disturbance in the muscarinic acetylcholine receptors.


Asunto(s)
Apoptosis , Compuestos Férricos/farmacología , Hipocampo/efectos de los fármacos , Ácido Nitrilotriacético/análogos & derivados , Estrés Oxidativo , Animales , Compuestos Férricos/administración & dosificación , Hipocampo/patología , Peróxido de Hidrógeno/administración & dosificación , Peróxido de Hidrógeno/farmacología , Masculino , Ratones , Ácido Nitrilotriacético/administración & dosificación , Ácido Nitrilotriacético/farmacología , Oxidación-Reducción , Ratas , Reacción en Cadena en Tiempo Real de la Polimerasa , Receptores Muscarínicos/metabolismo , Coloración y Etiquetado/métodos
6.
J Anesth ; 25(4): 618-20, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21630018

RESUMEN

Propofol and midazolam have a synergistic anesthetic action. One of the reasons for this is thought to be the inhibitory effect of propofol on midazolam metabolism. However, because both drugs bind strongly to serum protein, their interaction may not only involve the effects of propofol on midazolam metabolism, but may also involve propofol's effects on serum protein-binding. Against this background, we investigated the characteristics of midazolam binding to serum albumin, and evaluated the effects of both propofol and ketamine on this binding. Midazolam was added to a serum albumin solution with propofol or ketamine, and, after incubation for 1 h, albumin-free solution was separated from the sample and the midazolam concentration was measured using a high-performance liquid chromatography system. The albumin-unbound rate of midazolam was evaluated and compared with the rate in the control solution (only midazolam). Propofol significantly raised the rate of albumin-unbound free midazolam, while ketamine had no effect on the binding of midazolam to serum albumin. These findings suggest that the increase in albumin-unbound free midazolam brought about by propofol is involved in the synergistic effect of these two agents.


Asunto(s)
Anestésicos Intravenosos/farmacología , Midazolam/sangre , Midazolam/farmacología , Propofol/farmacología , Albúmina Sérica/metabolismo , Anestésicos Intravenosos/sangre , Cromatografía Líquida de Alta Presión/métodos , Sinergismo Farmacológico , Humanos , Midazolam/antagonistas & inhibidores , Unión Proteica/efectos de los fármacos
7.
Auton Neurosci ; 103(1-2): 114-20, 2003 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-12531405

RESUMEN

We investigated the relationship between electroencephalogram (EEG) activity and autonomic nervous system function using spectral analyses of EEG and heart rate variability (HRV) in healthy subjects during sleep. Eleven subjects were enrolled in this study. From EEG, the spectral edge frequencies (SEFs including SEF50, SEF90 and SEF95) were calculated. From electrocardiogram (ECG), the spectral powers of low-frequency band (LF: 0.04-0.15 Hz), high-frequency band (HF: 0.15-0.4 Hz) and the ratio of LF to HF (LF/HF) were calculated. During sleep, each set of data was obtained as the average of a 5-min measurement. We found that SEFs and LF/HF or LF decreased simultaneously and periodically, suggesting simultaneous depression of EEG activity and relative sympathetic activity, and SEFs significantly correlated with LF/HF and LF in all subjects during sleep, but not with HF. The existence of a clear correlation of SEFs with LF or LF/HF may offer a simple approach to estimate the relationship between EEG activity and autonomic nervous system function during sleep.


Asunto(s)
Electroencefalografía , Frecuencia Cardíaca/fisiología , Sueño/fisiología , Adulto , Electrocardiografía , Femenino , Humanos , Masculino , Valores de Referencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA